CS
BIIB icon

Comerica Securities’s Biogen BIIB Stock Holding History

Comerica Securities’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-55
Closed -$15.2K – 580
2022
Q4 		$15.2K Buy
+55
New +$15.5K ﹤0.01% 958
2019
Q2 		– Sell
-2,059
Closed -$487K – 415
2019
Q1 		$487K Sell
2,059
-148
-7% -$46.6K 0.05% 269
2018
Q4 		$664K Buy
2,207
+351
+19% +$112K 0.09% 214
2018
Q3 		$656K Buy
1,856
+716
+63% +$247K 0.08% 239
2018
Q2 		$331K Hold
1,140
– – 0.04% 326
2018
Q1 		$312K Hold
1,140
– – 0.04% 323
2017
Q4 		$363K Buy
1,140
+14
+1% +$4.49K 0.05% 304
2017
Q3 		$353K Hold
1,126
– – 0.05% 302
2017
Q2 		$306K Buy
1,126
+98
+10% +$25.9K 0.05% 313
2017
Q1 		$281K Buy
+1,028
New +$291K 0.04% 323
2015
Q4 		– Sell
-1,157
Closed -$338K – 328
2015
Q3 		$338K Sell
1,157
-1,084
-48% -$358K 0.09% 222
2015
Q2 		$905K Buy
2,241
+339
+18% +$136K 0.22% 120
2015
Q1 		$803K Buy
1,902
+934
+96% +$368K 0.21% 122
2014
Q4 		$329K Sell
968
-188
-16% -$60.8K 0.1% 198
2014
Q3 		$382K Buy
+1,156
New +$381K 0.13% 186

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Comerica Securities's BIIB Position: Q1 2023 in Review

Comerica Securities sold out of Biogen (BIIB) in Q1 2023, closing a stake of 55 shares — an estimated $15.2K sold.

Comerica Securities first reported a position in BIIB in Q3 2014 and held it in 15 quarters. The position peaked at $905K in Q2 2015. 1,001 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

  • Comerica Securities reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
  • Comerica Securities sold 55 Biogen shares in Q1 2023, an estimated $15.2K.
  • Comerica Securities first reported a position in Biogen in Q3 2014 and held it in 15 quarters.
  • Comerica Securities's Biogen position peaked at $905K in Q2 2015.
  • 1,001 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.